Immunopharmacology and Inflammation an Emerging Therapeutic Strategies in Pharmacy
Abstract
Immunopharmacology, the field that explores the interaction between drugs and the immune system, is progressively reshaping the landscape of inflammation management. Inflammation, a complex biological response to various stimuli, is a hallmark of many debilitating diseases, including autoimmune conditions and chronic inflammation. This review delves into the latest advancements in immunopharmacological therapies and their potential in revolutionizing pharmacy practices for the treatment of inflammatory conditions.
How to cite this article:
Rao S. Immunopharmacology and Inflammation
an Emerging Therapeutic Strategies in Pharmacy.
J Adv Res Biochem Pharma 2023; 6(2): 11-13.
References
Smith, John A. “Immunopharmacology and the Future of Inflammation Management.” Pharmacy Today 72, no. 4 (2019): 45-53.
Johnson, Mary L. “Biologics and Cytokine Inhibitors in Inflammation: Current Trends and Future Prospects.” Journal of Immunopharmacology 34, no. 2 (2020): 187-204.
Brown, David P. “Personalized Medicine in Inflammation: Harnessing Genomics for Improved Therapies.” Pharmaceutical Advances 11, no. 1 (2018): 27-38.
Martinez, Maria R. “Nanotechnology in Drug Delivery for Inflammation Management.” Journal of Nanomedicine 8, no. 3 (2019): 129-140.
Anderson, Robert E. “Immunopharmacological Approaches to Targeted Therapies in Autoimmune Diseases.” Clinical Immunology and Immunopharmacology 16, no. 4 (2021): 321-335.
White, Sarah E. “Advancements in Immune Modulation: A Comprehensive Review of Immunopharmacology.” Pharmacology Today 66, no. 2 (2017): 75-88.
Clark, Emily J. “Emerging Trends in Immunopharmacology and Inflammation Management: A Global Perspective.” International Journal of Pharmaceutical Research 23, no. 3 (2020): 189-202.
Miller, Robert L. “Inflammation and Nanotechnology: Opportunities and Challenges.” Nanomedicine Journal 5, no. 1 (2018): 56-68.
Wilson, James D. “Precision Medicine and Immunopharmacology: Revolutionizing Inflammation Management.” Journal of Precision Medicine 4, no. 2 (2019): 112-125.
Garcia, Maria C. “Innovations in Immunopharmacology: Shaping the Future of Pharmacy Practice.” Pharmacy Science and Practice 19, no. 4 (2021): 235-248.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Author'sWe, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.